Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 39 results.
User Information
Export Records
  1. 1.   Human Cripto-1 and Cripto-3 Protein Expression in Normal and Malignant Settings That Conflicts with Established Conventions
  2. Cuttitta,Frank; García-Sanmartín, Josune; Feng,Yang; Sunday, Mary Elizabeth; Kim, Young S; Martínez, Alfredo
  3. Cancers. 2024, Oct 23; 16(21):
  1. 2.   Ex vivo culture resting time impacts transplantation outcomes of genome-edited human hematopoietic stem and progenitor cells in xenograft mouse models
  2. Demirci, Selami; Khan,Muhammad; Hinojosa, Gabriela; Le, Anh; Leonard, Alexis; Essawi, Khaled; Gudmundsdottir, Bjorg; Liu, Xiong; Zeng, Jing; Inam, Zaina; Chu, Rebecca; Uchida, Naoya; Araki, Daisuke; London, Evan; Butt, Henna; Maitland, Stacy A; Bauer, Daniel E; Wolfe, Scot A; Larochelle, Andre; Tisdale, John F
  3. Cytotherapy. 2024, Jun ; 26(6): 641-648.
  1. 3.   Fetal-not Maternal-APOL1 Genotype Associated with Risk for Preeclampsia in Those with African Ancestry
  2. Reidy, Kimberly J; Hjorten, Rebecca C; Simpson, Claire L; Rosenberg, Avi Z; Rosenblum, Stacy D; Kovesdy, Csaba P; Tylavsky, Frances A; Myrie, Joseph; Ruiz, Bianca L; Haque, Soulin; Mozhui, Khyobeni; Nelson, George; David, Victor; Yang, Xiaoping; Suzuki, Masako; Jacob, Jack; Reznik, Sandra E; Kaskel, Frederick J; Kopp, Jeffrey B; Winkler, Cheryl; Davis, Robert L
  3. American journal of human genetics. 2018, Sep 6; 103(3): 367-376.
  1. 4.   In situ transcriptome characteristics are lost following culture adaptation of adult cardiac stem cells
  2. Kim, Taeyong; Echeagaray, Oscar H.; Wang, Bingyan J.; Casillas, Alexandria; Broughton, Kathleen M.; Kim, Bong-Hyun; Sussman, Mark A.
  3. Scientific Reports. 2018, Aug 13; 8(1): 12060.
  1. 5.   POGZ Is Required for Silencing Mouse Embryonic ß-like Hemoglobin and Human Fetal Hemoglobin Expression
  2. Gudmundsdottir, Bjorg; Gudmundsson, Kristbjorn O; Klarmann, Kimberly; Singh, Satyendra K; Sun, Lei; Singh, Shweta; Du, Yang; Coppola, Vincenzo; Stockwin, Luke; Nguyen, Nhu; Tessarollo, Lino; Thorsteinsson, Leifur; Sigurjonsson, Olafur E; Gudmundsson, Sveinn; Rafnar, Thorunn; Tisdale, John F; Keller, Jonathan
  3. Cell Reports. 2018, Jun 12; 23(11): 3236-3248.
  1. 6.   Laboratory correlates for a phase II trial of romidepsin in cutaneous and peripheral T-cell lymphoma
  2. Bates, S. E.; Zhan, Z. R.; Steadman, K.; Obrzut, T.; Luchenko, V.; Frye, R.; Robey, R. W.; Turner, M.; Gardner, E. R.; Figg, W. D.; Steinberg, S. M.; Ling, A.; Fojo, T.; To, K. W.; Piekarz, R. L.
  3. British Journal of Haematology. 2010, Jan; 148(2): 256-267.
  1. 7.   C/EBP beta regulates body composition, energy balance-related hormones and tumor growth
  2. Staiger, J.; Lueben, M. J.; Berrigan, D.; Malik, R.; Perkins, S. N.; Hursting, S. D.; Johnson, P. F.
  3. Carcinogenesis. 2009 30(5): 832-840.
  1. 8.   Lack of adrenomedullin in the mouse brain results in behavioral changes, anxiety, and lower survival under stress conditions
  2. Fernandez, A. P.; Serrano, J.; Tessarollo, L.; Cuttitta, F.; Martinez, A.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2008 105(34): 12581-12586.
  1. 9.   Transplacental exposure to inorganic arsenic at a hepatocarcinogenic dose induces fetal gene expression changes in mice indicative of aberrant estrogen signaling and disrupted steroid metabolism
  2. Liu, J.; Xie, Y. X.; Cooper, R.; Duchanne, D. M. K.; Tennant, R.; Diwan, B. A.; Waalkes, M. P.
  3. Toxicology and Applied Pharmacology. 2007, May; 220(3): 284-291.
  1. 10.   Environmental genotoxicants/carcinogens and childhood cancer: Bridgeable gaps in scientific knowledge
  2. Anderson, L. M.
  3. Mutation Research-Genetic Toxicology and Environmental Mutagenesis. 2006, Sep; 608(2): 136-156.
  1. 11.   The adaptive immune response in neonatal cerebral white matter damage
  2. Leviton, A.; Dammann, O.; Durum, S. K.
  3. Annals of Neurology. 2005, DEC; 58(6): 821-828.
  1. 12.   The Ter mutation in the dead end gene causes germ cell loss and testicular germ cell tumours
  2. Youngren, K. K.; Coveney, D.; Peng, X. N.; Bhattacharya, C.; Schmidt, L. S.; Nickerson, M. L.; Lamb, B. T.; Deng, J. M.; Behringer, R. R.; Capel, B.; Rubin, E. M.; Nadeau, J. H.; Matin, A.
  3. Nature. 2005, MAY 19; 435(7040): 360-364.
  1. 13.   Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success
  2. Hiby, S. E.; Walker, J. J.; O'Shaughnessy, K. M.; Redman, C. W. G.; Carrington, M.; Trowsdale, J.; Moffett, A.
  3. Journal of Experimental Medicine. 2004, OCT 18; 200(8): 957-965.
  1. 14.   The mutagenic effects of 7,12-dimethylbenz[a]anthacene, 3-methylcholanthrene and benzo[a]pyrene to the developing Syrian hamster fetus measured by an in vivo/in vitro mutation assay
  2. Donovan, P. J.; Smith, G. T.; Nardone, R.
  3. Mutation Research-Fundamental and Molecular Mechanisms of Mutagenesis. 2004, OCT 4; 554(1-2): 111-120.
  1. 15.   Ablation of TrkA function in the immune system causes B cell abnormalities
  2. Coppola, V.; Barrick, C. A.; Southon, E. A.; Celeste, A.; Wang, K.; Chen, B.; Haddad, E. B.; Yin, J.; Nussenzweig, A.; Subramaniaml, A.; Tessarollo, L.
  3. Development. 2004, OCT; 131(20): 5185-5195.
  1. 16.   C/EBP alpha deficiency results in hyperproliferation of hematopoietic progenitor cells and disrupts macrophage development in vitro and in vivo
  2. Heath, V.; Suh, H. C.; Holman, M.; Renn, K.; Gooya, J. M.; Parkin, S.; Klarmann, K. D.; Ortiz, M.; Johnson, P.; Keller, J.
  3. Blood. 2004, SEP 15; 104(6): 1639-1647.
  1. 17.   Predictive values of traditional animal bioassay studies for human perinatal carcinogenesis risk determination
  2. Anderson, L. M.
  3. Toxicology and Applied Pharmacology. 2004, SEP 1; 199(2): 162-174.
  1. 18.   Introduction and overview. Perinatal carcinogenesis: growing a node for epidemiology, risk management, and animal studies
  2. Anderson, L. M.
  3. Toxicology and Applied Pharmacology. 2004, SEP 1; 199(2): 85-90.
  1. 19.   Alterations in mast cell function and survival following in vitro infection with human immunodeficiency viruses-1 through CXCR4
  2. Taub, D. D.; Mikovits, J. A.; Nilsson, G.; Schaffer, E. M.; Key, M. L.; Petrow-Sadowski, C.; Ruscetti, F. W.
  3. Cellular Immunology. 2004, AUG; 230(2): 65-80.
  1. 20.   In utero exposure to anti-HIV drugs causes mitochondrial damage and mtDNA depletion in umbilical cord tissue from human infants and fetal Erythrocebus Patas monkeys
  2. Divi, R.; Leonard, S.; Kuo, M.; Nagashima, K.; St Claire, M.; Wade, N.; Walker, V.; Poirier, M.
  3. Biochimica et Biophysica Acta-Bioenergetics. 2004, JUN 30; 1657(Suppl. 1): 97-98.
  1. 21.   Bayesian analysis for cystic fibrosis risks in prenatal and carrier screening
  2. Ogino, S.; Wilson, R. B.; Gold, B.; Hawley, P.; Grody, W. W.
  3. Genetics in Medicine. 2004, SEP-OCT; 6(5): 439-449.
  1. 22.   Mitochondrial toxicity in fetal Erythrocebus patas monkeys exposed transplacentally to zidovudine plus lamivudine
  2. Gerschenson, M.; Nguyen, V.; Ewings, E. L.; Ceresa, A.; Shaw, J. A.; St Claire, M. C.; Nagashima, K.; Harbaugh, S. W.; Harbaugh, J. W.; Olivero, O. A.; Divi, R. L.; Albert, P. S.; Poirier, M. C.
  3. Aids Research and Human Retroviruses. 2004 20(1): 91-100.
  1. 23.   Hematopoietic, angiogenic and eye defects in Meis1 mutant animals
  2. Hisa, T.; Spence, S. E.; Rachel, R. A.; Fujita, M.; Nakamura, T.; Ward, J. M.; Devor-Henneman, D. E.; Saiki, Y.; Kutsuna, H.; Tessarollo, L.; Jenkins, N. A.; Copeland, N. G.
  3. Embo Journal. 2004 23(2): 450-459.
  1. 24.   A germ-line insertion in the Birt-Hogg-Dube (BHD) gene gives rise to the Nihon rat model of inherited renal cancer
  2. Okimoto, K.; Sakurai, J.; Kobayashi, T.; Mitani, H.; Hirayama, Y.; Nickerson, M. L.; Warren, M. B.; Zbar, B.; Schmidt, L. S.; Hino, O.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2004 101(7): 2023-2027.
  1. 25.   JAK2 contributes to the intrinsic capacity of primary hematopoietic cells to respond to stem cell factor
  2. Radosevic, N.; Winterstein, D.; Keller, J. R.; Neubauer, H.; Pfeffer, K.; Linnekin, D.
  3. Experimental Hematology. 2004 32(2): 149-156.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel